Hematopoietic stem cells, that form mature blood cells, require a very precise amount of protein to function -- and defective regulation of protein production is common in certain types of aggressive human blood cancers. Now, a research team has uncovered a completely new mechanism that controls how proteins are produced to direct stem cell function.
"Our research is potentially important for life-threatening blood cancers characterized by dysfunctional stem cells -- which are common in elderly people. High protein synthesis levels could represent an Achilles' heel to eradicating cancer-initiating cells", explains research team leader.
They uncovered a new important function of pseudouridine, the most common type of RNA modification in human cells.
RNA is the essential molecule that decodes the genetic information in humans. It is emerging that the chemical structure of RNA molecules is extensively modified by specific enzymes normally present in our cells, which are commonly found to be altered in severe medical syndromes and various types of cancers. However, the contribution of RNA modifications in human development and disease is still mostly unexplored.
The team's key discovery was that stem cells lacking an enzyme responsible for pseudouridine modification of RNA, known as PUS7, produce abnormal amounts of protein. This protein overload leads to unbalanced stem cell growth and dramatically blocks differentiation to blood cells.
They uncovered that the PUS7 enzyme is capable of introducing a pseudouridine modification into previously uncharacterized, non-coding-protein RNA molecules that they denoted as miniTOGs (mTOGs). The presence of pseudouridine "activates" mTOGs to strongly suppress the stem cell protein synthesis machinery. This ensures that the correct amount of proteins is made.
"Our work illustrates that this exquisite control mechanism -- regulated by PUS7 and pseudouridine -- is critical to adjusting the amount of proteins needed for human stem cells to grow and produce blood", says the senior author.
Since pseudouridine modifications may affect various RNA molecules in different types of normal and malignant cells, "our discoveries pave the way for future avenues of research aimed at exploring the role of pseudouridine in human development disease", concludes the senior author.
http://www.cell.com/cell/fulltext/S0092-8674(18)30288-5
Latest News
Complete vascularization of…
By newseditor
Posted 28 Mar
Immune cells identified as…
By newseditor
Posted 28 Mar
TB blood test which could d…
By newseditor
Posted 27 Mar
Propionate supplementation…
By newseditor
Posted 27 Mar
Role of human Kallistatin i…
By newseditor
Posted 26 Mar
Other Top Stories
35 kidney genes linked to chronic kidney disease risk
Read more
Two different parts of the brain helps us to calculate when to make…
Read more
Neurons process information differently depending on their location
Read more
Evaluation of Human Cell Surface Proteins (Surfaceome)
Read more
Poor language development in autism is associated with widespread g…
Read more
Protocols
Spatial proteomics in neuro…
By newseditor
Posted 28 Mar
All-optical presynaptic pla…
By newseditor
Posted 23 Mar
Epigenomic tomography for p…
By newseditor
Posted 20 Mar
A mouse DRG genetic toolkit…
By newseditor
Posted 17 Mar
An optogenetic method for t…
By newseditor
Posted 13 Mar
Publications
A microfluidic platform int…
By newseditor
Posted 28 Mar
Salmonella manipulates macr…
By newseditor
Posted 28 Mar
BHLHE40/41 regulate microgl…
By newseditor
Posted 28 Mar
Balancing neuronal activity…
By newseditor
Posted 28 Mar
OSBP-mediated PI(4)P-choles…
By newseditor
Posted 28 Mar
Presentations
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
RNA structure and functions
By newseditor
Posted 19 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar